US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Medical Devices ETF

52.04

+0.14000.27%

Volume:1.39M

Turnover:71.71M

Market Cap:3.25B

PE:13.03

High:52.11

Open:52.11

Low:51.36

Close:51.90

52wk High:64.71

52wk Low:47.37

Shares:62.40M

Float Shares:62.40M

Volume Ratio:0.53

T/O Rate:2.22%

Dividend:0.32

Dividend Rate:0.62%

EPS(TTM):3.99

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

Becton Dickinson (BDX) Hits STANCE Trial Milestone, Is The Stock Fully Valued?

Simply Wall St.

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12

Edwards Lifesciences Strategy Chief Donald Bobo Plans Retirement by Mid-2027

Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

BD EVP, Chief Revenue Officer Michael Feld Sells 165 Shares for $31,100.85

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Abbott Laboratories' Stroke Treatment Device Receives CE Mark

MT Newswires Live

Abbott - to Expand Amulet 360 Use Across Europe in Coming Weeks

THOMSON REUTERS

Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark

THOMSON REUTERS

Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke

THOMSON REUTERS

Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe

Becton Dickinson Reaches 50% Enrollment in Breast Surgery Trial

MT Newswires Live

Becton Dickinson announces STANCE clinical trial enrollment milestone

Bd Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

THOMSON REUTERS

Top Stryker Executive Makes Eye-Catching Move With Fresh Stock Sale

Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IHI/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHI\",,,,,undefined,":{"symbol":"IHI","market":"US","secType":"STK","nameCN":"iShares U.S. Medical Devices ETF","latestPrice":52.04,"timestamp":1789668972581,"preClose":51.9,"halted":0,"volume":1386196,"delay":0,"changeRate":0.002697495183044327,"floatShares":62399999,"shares":62399999,"eps":3.993308,"marketStatus":"Trading","change":0.14,"latestTime":"09-17 14:16:20 EDT","open":52.11,"high":52.11,"low":51.36,"amount":71709721.1348,"amplitude":0.014451,"askPrice":52.05,"askSize":307,"bidPrice":52.04,"bidSize":698,"shortable":3,"etf":1,"ttmEps":3.993308,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":51.9,"sharesOutstanding":60300000,"nav":51.76791,"aum":3546101835,"dividendRate":0.006184,"bidAskSpread":0.000209,"preHourTrading":{"tag":"盘前","latestPrice":52.45,"preClose":51.9,"latestTime":"09:20 EDT","volume":1350,"amount":70686.09855,"timestamp":1789651211046,"change":0.55,"changeRate":0.010597,"amplitude":0.010597},"postHourTrading":{"tag":"盘后","latestPrice":52.05,"preClose":51.9,"latestTime":"19:50 EDT","volume":8226,"amount":427134.0876,"timestamp":1789602655033,"change":0.15,"changeRate":0.00289,"amplitude":0.00289},"volumeRatio":0.529115,"impliedVol":0.2221,"impliedVolPercentile":0.5697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHI\",,,,,undefined,":{"symbol":"IHI","floatShares":62399999,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.529115,"shares":62399999,"dividePrice":0.3218,"high":52.11,"amplitude":0.014451,"preClose":51.9,"low":51.36,"week52Low":47.365,"pbRate":"--","week52High":64.71,"institutionHeld":0,"latestPrice":52.04,"committee":0.389055,"eps":3.993308,"divideRate":0.006184,"volume":1386196,"delay":0,"ttmEps":3.993308,"open":52.11,"prevYearClose":62.15,"prevWeekClose":50.88,"prevMonthClose":54.97,"prevQuarterClose":49.41,"fiveDayClose":50.9,"twentyDayClose":56.64,"sixtyDayClose":49.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IHI\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IHI","amount":0.080895,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"iShares Dow Jones U.S. Medical D","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IHI","amount":0.0751,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Dow Jones U.S. Medical D","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IHI","amount":0.043039,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares Dow Jones U.S. Medical D","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IHI","amount":0.063101,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Dow Jones U.S. Medical D","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IHI","amount":0.060878,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares Dow Jones U.S. Medical D","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IHI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.154631,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.374991,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.125681,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.053508,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.190056,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IHI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IHI\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663017647","title":"Abbott, Vistra, Unity, United, Nu: Insider Shockwave","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017647?lang=en_us&edition=fundamental","pubTime":"2026-08-29 21:01","pubTimestamp":1788008465,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($ABT)), (($VST)), (($U)), (($UAL)) and (($NU)). Here is a breakdown of their recent trades and their v...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/abbott-vistra-unity-united-nu-insider-shockwave?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/abbott-vistra-unity-united-nu-insider-shockwave?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","IHI","LU0208291251.USD","BK4588","IE00B2B36J28.USD","XTN","BK4008","LU2133065610.SGD","BK4585","IE00B4R5TH58.HKD","ABT","SG9999002232.USD","LU1721429741.USD","LU0289739699.SGD","BK4592","BK4533","LU0114720955.EUR","UAL","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BK4568","LU0320765489.SGD","PJP","SG9999004303.SGD","BK4211","LU2324357040.USD","LU0868494617.USD","LU0170899867.USD","LU1989763690.USD","BK4082","IYT","LU2089984988.USD","LU2237957811.SGD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","SGXZ41872573.SGD","LU0234572021.USD","LU0122379950.USD","TMED","BK4500","LU2211815571.USD","LU1721429402.USD","UNTY","LU0882574055.USD","LU2468319806.SGD","UBCP","JETS","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019352","title":"Becton Dickinson (BDX) Hits STANCE Trial Milestone, Is The Stock Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019352?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:30","pubTimestamp":1787959830,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) stock is back in focus after the company reported that its STANCE clinical trial of GalaFLEX LITE Scaffold in breast revision surgery hit a first enrollment milestone, triggering a planned interim analysis.\nAgainst this backdrop, Becton Dickinson shares trade at US$189.52, with the stock posting a 30 day share price return of 12.54% and a 90 day share price return of 28.82%. The 1 year total shareholder return of 28.03% contrasts with a weaker 3 year record and points...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-hits-stance-trial-milestone-is-the-stoc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-hits-stance-trial-milestone-is-the-stoc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0433182093.SGD","LU0289961442.SGD","LU0985489474.SGD","LU0878866978.SGD","LU1894683264.USD","LU1854103824.USD","LU1150488218.USD","IHI","LU1571399168.USD","LU0072461881.USD","LU1894683348.USD","BK4585","LU1489326972.SGD","LU0006061336.USD","BK4588","LU0511384066.AUD","LU1854104046.USD","BDX","LU0289739343.SGD","LU0130103400.USD","LU0130518102.USD","BK4504","LU0985320562.USD","LU0162691827.USD","IE00BFXG1179.USD","LU1059921491.USD","LU1150488135.SGD","BDX.AU","LU0477156797.USD","BK4082","LU0068578508.USD","BK7067","LU0648000940.SGD","LU0266013472.USD","LU1201861165.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663401575","title":"Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2663401575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663401575?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:28","pubTimestamp":1787952480,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  advanced 2.84% to $14.48 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Perrigo Co. PLC closed 39.62% below its 52-week high of $23.98, which the company reached on August 28th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Procter & Gamble Co.  rose 0.45% to $143.78, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 805,910 below its 50-day average volume of 3.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","FTXH","FHLC","IE00BKDWB100.SGD","LU0289739699.SGD","SG9999013999.USD","TRUH","IE00B19Z3581.USD","LU1267930813.SGD","JNJ","LU1721429402.USD","JDOC","IYH","SG9999014559.SGD","VHT","XLP","PG","LU0122379950.USD","TRUO","LU0795875086.SGD","LU0237698245.USD","LU1228905540.USD","IE00B4R5TH58.HKD","RXL","GDOC","IE00BVYPNV92.GBP","TMED","IE00BLSP4452.SGD","UGE","LU1629891620.HKD","PRGO","LU0432979614.USD","IHI","MEDX","IXJ","SG9999014567.USD","FSTA","LU1032466523.USD","ABT","XLV","BK4534","LU0912757837.SGD","LU0792757196.USD","PJP","LU1244550221.USD","LU1721429741.USD","IE000MB6IJN5.SGD","LU1228905037.USD","BMED","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013044","title":"Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013044","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013044?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:33","pubTimestamp":1787949220,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences CVP EMEACLA Annette Bruls sells 2,644 shares worth $237,903.12Edwards Lifesciences officer Annette Bruls, CVP, EMEACLA, sold 2,644 common shares on Aug. 28, 2026 at $89.98.Directl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8xz2jT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0058720904.USD","SG9999013999.USD","IHI","BK4504","LU0823416689.USD","IE00BYQQ9H92.USD","LU0345774631.USD","LU0289739699.SGD","EW","SG9999001176.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","BK4588","BK4567","LU0345774391.USD","SGXZ57979304.SGD","SG9999001176.SGD","IE00BN0W2V16.EUR","BK4585","AGNG","IE00BFXG0V08.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013287","title":"Edwards Lifesciences Strategy Chief Donald Bobo Plans Retirement by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013287","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013287?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:16","pubTimestamp":1787948198,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences strategy chief Donald Bobo plans retirement by mid-2027Edwards Lifesciences received notice that Donald E. Bobo Jr. will retire as corporate vice president, strategy and corporate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbMyq4w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","SG9999001176.USD","LU0823416689.USD","LU0345774631.USD","IE00BN0W2V16.EUR","BK4504","IE00BFXG0V08.USD","BMED","LU0345774391.USD","IE00BN0W2W23.USD","BK4082","IE00BN0W2T93.GBP","BK4567","SG9999013999.USD","IE00BYQQ9H92.USD","EW","SG9999001176.SGD","BK4585","LU0289739699.SGD","SGXZ57979304.SGD","BK4588","LU0058720904.USD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603518","title":"Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603518?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:19","pubTimestamp":1787865588,"startTime":"0","endTime":"0","summary":"Abbott CEO Robert B. Ford disposes of $ US 46.17 million in common sharesAbbott Laboratories Chairman and CEO Robert B. Ford reported option exercises, acquiring 398,832 common shares on Aug. 25, 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8ZPBwh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","BK4533","LU0882574055.USD","SGXZ41872573.SGD","LU1721429741.USD","BK4581","BK4566","LU1691799644.USD","LU2133065610.SGD","BK4585","SG9999002232.USD","BK4504","LU1057294990.SGD","IHI","LU0058720904.USD","LU0234572021.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4082","LU1989763427.SGD","LU2211815571.USD","SG9999002224.SGD","LU0114720955.EUR","ABT","LU2237957902.USD","TMED","PJP","LU0432979614.USD","LU2468319806.SGD","LU0868494617.USD","LU0122379950.USD","BK4588","IE00BJT1NW94.SGD","LU0320765489.SGD","LU1914381329.SGD","LU2112291526.USD","BK4568","LU0170899867.USD","LU2237957811.SGD","LU1061106388.HKD","IE00B2B36J28.USD","LU0211331839.USD","LU0266013472.USD","LU0208291251.USD","SG9999004303.SGD","LU1023059063.AUD","LU1721429402.USD","LU0070302665.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033089","title":"Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033089?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:54","pubTimestamp":1787864040,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  rose 1.68% to $157.69 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.72% to 7,730.99 and the Dow Jones Industrial Average  rising 0.20% to 53,569.44.This was the stock's third consecutive day of gains.Agilent Technologies Inc. closed 1.76% short of its 52-week high of $160.51, which the company reached on August 21st.The stock outperformed some of its competitors Thursday, as Thermo Fisher Scientific Inc.  fell 0.47% to $630.70, Danaher Corp.  rose 0.15% to $215.68, and Abbott Laboratories  fell 2.20% to $111.59.Trading volume  eclipsed its 50-day average volume of 2.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2355687059.USD","HRTS","BK4534","LU2125909247.SGD","LU1974910355.USD","LU0122379950.USD","IE00B19Z8X17.USD","LU0058720904.USD","TMED","BK4504","BK4592","FMED","IHI","LU0170899867.USD","LU0557290698.USD","LU0820561818.USD","LU1280957306.USD","LU1914381329.SGD","BK4585","LU1803068623.USD","LU0432979614.USD","IE00B19Z9505.USD","IE0009355771.USD","SG9999002232.USD","A","LU1548497426.USD","LU2211814178.USD","PJP","SG9999002224.SGD","LU2229751404.USD","TMO","IE00BFTCPJ56.SGD","SG9999004303.SGD","LU0823416689.USD","BK4566","IE00BQXX3D17.EUR","LU2264538146.SGD","LU0187121727.USD","LU2468319806.SGD","LU2720916845.USD","LU1854103824.USD","ABT","GNMX","DHR","LU0097036916.USD","LU1023059063.AUD","LU0390134368.USD","SGXZ23171101.USD","LU0310800379.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703343","title":"Medtronic PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703343?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:39","pubTimestamp":1787863140,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  shed 2.23% to $89.97 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.72% to 7,730.99 and the Dow Jones Industrial Average  rising 0.20% to 53,569.44.Medtronic PLC closed 15.39% below its 52-week high of $106.33, which the company reached on November 26th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 1.57% to $265.77, Danaher Corp.  rose 0.15% to $215.68, and Abbott Laboratories  fell 2.20% to $111.59.Trading volume  remained 190,833 below its 50-day average volume of 7.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","ABT","LU0053666078.USD","LU0689472784.USD","LU1267930813.SGD","JDOC","FHLC","LU1721429402.USD","LU1721429741.USD","LU2896262040.SGD","PJP","SG9999001440.SGD","JNJ","LU2324357040.USD","IYH","IHI","GDOC","RXL","TMED","MDT","VHT","FTXH","IE00BSNM7G36.USD","IHE","LU1066051811.HKD","FMED","LU1221951129.SGD","SGXZ41872573.SGD","DHR","BMED","LU2125909247.SGD","LU0114720955.EUR","LU0985320562.USD","BK4534","LU0098860793.USD","LU1430594728.SGD","LU0314106906.USD","XLV","IE0004445239.USD","IE00BJT1NW94.SGD","LU0689626769.HKD","LU2471134952.CNY","MEDX","TRUH","LU2756315664.SGD","SG9999002232.USD","IE00BQXX3C00.GBP","BK4007","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662333560","title":"BD EVP, Chief Revenue Officer Michael Feld Sells 165 Shares for $31,100.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2662333560","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662333560?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:30","pubTimestamp":1787862609,"startTime":"0","endTime":"0","summary":"BD EVP, Chief Revenue Officer Michael Feld sells 165 shares for $31,100.85BD EVP, Chief Revenue Officer Michael Feld sold 165 common shares on Aug. 26, 2026 at $188.49.Directly held stake fell to 19,7","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLKGV9H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BD EVP, Chief Revenue Officer Michael Feld Sells 165 Shares for $31,100.85","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289961442.SGD","LU0985320562.USD","LU1854103824.USD","LU0130103400.USD","BK4585","LU0985489474.SGD","LU1489326972.SGD","LU0878866978.SGD","LU0433182093.SGD","LU1854104046.USD","LU0068578508.USD","LU0130518102.USD","LU0072461881.USD","LU0648000940.SGD","IHI","LU1894683348.USD","BK4082","LU1150488218.USD","LU1150488135.SGD","BK4588","LU1059921491.USD","IE00BFXG1179.USD","LU0289739343.SGD","LU0162691827.USD","LU1571399168.USD","LU0006061336.USD","BK4504","LU0266013472.USD","LU1201861165.SGD","LU1894683264.USD","LU0477156797.USD","LU0511384066.AUD","BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080831","title":"Stryker to participate in the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080831?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:00","pubTimestamp":1787857200,"startTime":"0","endTime":"0","summary":"Portage, Michigan, Aug.  27, 2026  -- Stryker  will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. . A simultaneous live audio webcast and replay of the session can be accessed atStryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries:Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com  For medi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352354/0/en/stryker-to-participate-in-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","IE0002270589.USD","LU0640476718.USD","LU0211328371.USD","BK4559","LU0128525929.USD","LU0289960550.SGD","LU2506952097.USD","LU0128525689.USD","XBI","SYK","LU0128526141.USD","FTXO","LU1267930227.SGD","WFC","LU0052756011.USD","LU0310799852.SGD","LU0432979614.USD","LU1267930573.SGD","LU1668664300.SGD","LU0980610538.SGD","LU1035773651.USD","LU0029864427.USD","LABU","LU0058720904.USD","LU0477156953.USD","LU0690374961.EUR","IYF","LU1791710582.SGD","TFNS","LU1506573853.SGD","XLV","HCSG","GB00B4QBRK32.GBP","LU2089984988.USD","BK4581","IHI","LU1791710400.SGD","LU1791807156.HKD","IE00B19Z3581.USD","LU0211327993.USD","LU0868494708.USD","LU0106831901.USD","LU0787776722.HKD","BK4582","LU0070302665.USD","LU1280957306.USD","KBWB","LU2324357040.USD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662833310","title":"Abbott Laboratories' Stroke Treatment Device Receives CE Mark","url":"https://stock-news.laohu8.com/highlight/detail?id=2662833310","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662833310?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:35","pubTimestamp":1787837729,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  has received the CE Mark for its stroke treatment device Amulet 360 Left Atrial Appendage Occluder, the company said Thursday.The device is designed to reduce risk of stroke in patients with atrial fibrillation not caused by a heart valve issue, Abbott said.The CE Mark approval for the device was supported by recent clinical data that showed Amulet 360 met benchmarks for safety and effectiveness, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2112291526.USD","LU1057294990.SGD","IHI","BK4588","LU2211815571.USD","PJP","LU2324357040.USD","ABT","BK4533","LU0266013472.USD","LU0882574055.USD","SG9999004303.SGD","LU0211331839.USD","BK4082","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1721429402.USD","LU1023059063.AUD","LU2237957811.SGD","IE00BJT1NW94.SGD","BK4581","IE00BJJMRZ35.SGD","TMED","LU0114720955.EUR","LU0170899867.USD","IE00B2B36J28.USD","LU1989763427.SGD","LU0289739699.SGD","ABT.AU","LU1989763690.USD","IE0002141913.USD","LU2089984988.USD","SG9999002232.USD","LU1721429741.USD","LU2237957902.USD","LU0432979614.USD","LU0070302665.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","IE0009355771.USD","LU1691799644.USD","LU2133065610.SGD","LU0122379950.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","BK4568","SGXZ41872573.SGD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735700","title":"Abbott - to Expand Amulet 360 Use Across Europe in Coming Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735700?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:03","pubTimestamp":1787835797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1H1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGXZ41872573.SGD","LU0070302665.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","SG9999002224.SGD","BK4566","LU0266013472.USD","LU0868494617.USD","LU2211815571.USD","LU2133065610.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","PJP","BK4533","IE00BJJMRZ35.SGD","LU0432979614.USD","IE0009355771.USD","SG9999002232.USD","ABT","LU2112291526.USD","BK4592","IHI","BK4581","LU0122379950.USD","LU2237957902.USD","LU2324357040.USD","LU0320765489.SGD","TMED","LU1721429402.USD","LU1721429741.USD","LU0234572021.USD","BK4504","IE0002141913.USD","LU0170899867.USD","LU1057294990.SGD","SG9999004303.SGD","IE00B2B36J28.USD","LU0211331839.USD","LU0289739699.SGD","LU0208291251.USD","BK4082","LU0058720904.USD","LU0882574055.USD","LU1989763427.SGD","LU1989763690.USD","LU1023059063.AUD","LU1061106388.HKD","LU2468319806.SGD","BK4588","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700741","title":"Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700741?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:03","pubTimestamp":1787835797,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1H1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU0234572021.USD","LU0058720904.USD","SG9999002232.USD","LU0122379950.USD","LU1691799644.USD","LU1721429402.USD","SG9999004303.SGD","SGXZ41872573.SGD","BK4533","LU2237957902.USD","BK4566","LU1061106388.HKD","LU2468319806.SGD","LU2133065610.SGD","IE00B4R5TH58.HKD","LU2324357040.USD","LU0114720955.EUR","LU0211331839.USD","LU0266013472.USD","LU0170899867.USD","SGXZ23171101.USD","ABT","LU0320765489.SGD","LU2237957811.SGD","BK4581","IE00BFTCPJ56.SGD","BK4585","LU2089984988.USD","IHI","BK4588","LU1023059063.AUD","LU1989763427.SGD","PJP","LU1057294990.SGD","IE00BJT1NW94.SGD","TMED","SG9999002224.SGD","LU0868494617.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0208291251.USD","LU1914381329.SGD","LU2211815571.USD","BK4082","LU1989763690.USD","BK4568","LU0070302665.USD","LU0432979614.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700732","title":"Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700732?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:03","pubTimestamp":1787835797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU1691799644.USD","BK4566","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4581","TMED","LU0114720955.EUR","BK4082","PJP","LU0234572021.USD","LU2237957902.USD","LU0208291251.USD","SG9999002224.SGD","LU1914381329.SGD","LU0070302665.USD","SGXZ41872573.SGD","SG9999004303.SGD","LU2133065610.SGD","BK4592","IE00B4R5TH58.HKD","LU2112291526.USD","LU2324357040.USD","LU1057294990.SGD","LU0432979614.USD","LU1061106388.HKD","LU1721429402.USD","LU2089984988.USD","IE0009355771.USD","IHI","BK4504","LU0266013472.USD","LU2237957811.SGD","SG9999002232.USD","LU0882574055.USD","LU0058720904.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU1721429741.USD","LU2211815571.USD","ABT","BK4588","LU0170899867.USD","LU1023059063.AUD","IE0002141913.USD","LU0122379950.USD","LU0868494617.USD","BK4568","LU1989763690.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662007837","title":"Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2662007837","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662007837?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:02","pubTimestamp":1787835728,"startTime":"0","endTime":"0","summary":"Abbott wins CE Mark for Amulet 360 left atrial appendage occluder in EuropeAbbott won CE Mark for its next-generation Amulet 360 left atrial appendage occluder for non-valvular AFib patients at stroke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8znFky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211815571.USD","LU2237957811.SGD","LU0289739699.SGD","LU0432979614.USD","LU2133065610.SGD","TMED","LU1989763690.USD","LU0122379950.USD","SG9999004303.SGD","LU1989763427.SGD","LU1691799644.USD","BK4568","LU2237957902.USD","LU0058720904.USD","SG9999002232.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","LU2089984988.USD","PJP","IE0009355771.USD","LU0211331839.USD","IE00B4R5TH58.HKD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU1061106388.HKD","SG9999002224.SGD","IE00BJT1NW94.SGD","BK4592","BK4566","LU0208291251.USD","LU2468319806.SGD","LU0114720955.EUR","LU2324357040.USD","BK4585","LU1721429402.USD","LU1721429741.USD","BK4533","BK4581","IE0002141913.USD","SGXZ41872573.SGD","BK4082","LU0170899867.USD","LU1914381329.SGD","LU2112291526.USD","IHI","ABT","BK4588","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662670497","title":"Becton Dickinson Reaches 50% Enrollment in Breast Surgery Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662670497","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662670497?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:43","pubTimestamp":1787831011,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Co.  said Thursday that its clinical study evaluating GalaFLEX LITE Scaffold in breast revision surgery for capsular contracture has treated 274 patients across 33 active US states.The total number shows over 50% of planned enrollment and has triggered the first planned interim analysis, the medical technology company said.The trial evaluates the bioabsorbable device for treating capsular contracture, a complication where scar tissue hardens around implants, the company said.Shares of the company were down less than 1% in recent Thursday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0130103400.USD","LU0985489474.SGD","BK7067","LU0006061336.USD","LU0985320562.USD","LU0072461881.USD","BDX","BK4585","LU0289739343.SGD","BK4588","BDX.AU","LU1571399168.USD","LU1854103824.USD","LU1150488135.SGD","LU1150488218.USD","LU0266013472.USD","LU1059921491.USD","LU1201861165.SGD","BK4082","LU1854104046.USD","IHI","LU0289961442.SGD","LU0648000940.SGD","LU0511384066.AUD","LU0162691827.USD","LU0477156797.USD","LU0130518102.USD","IE00BFXG1179.USD","LU1894683348.USD","LU0433182093.SGD","BK4504","LU0068578508.USD","LU0878866978.SGD","LU1894683264.USD","LU1489326972.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662470993","title":"Becton Dickinson announces STANCE clinical trial enrollment milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2662470993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662470993?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:55","pubTimestamp":1787828139,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) announced a milestone in its advanced tissue regeneration strategy and expansion efforts with the STANCE clinical trial eval...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/becton-dickinson-announces-stance-clinical-trial-enrollment-milestone-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/becton-dickinson-announces-stance-clinical-trial-enrollment-milestone-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1150488218.USD","IDNA","LU0130518102.USD","BDX","LU0433182093.SGD","LU0006061336.USD","LU0648000940.SGD","LU0130103400.USD","BK4504","LU0511384066.AUD","LU1854103824.USD","LU1894683348.USD","LU1894683264.USD","LU0985320562.USD","MEDX","LU0266013472.USD","LU0878866978.SGD","GDOC","IE00BFXG1179.USD","NVIB","LU0068578508.USD","LU1059921491.USD","LU0162691827.USD","BK4588","LU1150488135.SGD","LU1854104046.USD","IHI","LU0289961442.SGD","LU1571399168.USD","HYLG","LU0985489474.SGD","BK4082","LU0477156797.USD","LU0072461881.USD","LU1489326972.SGD","LU1201861165.SGD","LU0289739343.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706403","title":"Bd Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706403?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O10P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0477156797.USD","LU0289739343.SGD","LU0878866978.SGD","BK4588","BK4504","LU0072461881.USD","LU0130103400.USD","LU0068578508.USD","LU0130518102.USD","LU0006061336.USD","BK4082","LU1489326972.SGD","LU1894683348.USD","LU0511384066.AUD","LU0648000940.SGD","LU1150488218.USD","BDX","LU1854104046.USD","LU0985489474.SGD","LU0433182093.SGD","LU1201861165.SGD","LU1894683264.USD","LU0266013472.USD","LU1854103824.USD","LU0289961442.SGD","IE00BFXG1179.USD","LU1571399168.USD","IHI","BK4585","LU1059921491.USD","LU0162691827.USD","LU0985320562.USD","LU1150488135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662724848","title":"Top Stryker Executive Makes Eye-Catching Move With Fresh Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2662724848","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662724848?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:11","pubTimestamp":1787796686,"startTime":"0","endTime":"0","summary":"New insider activity at Stryker ( ($SYK) ) has taken place on August 26, 2026. Group President Dylan Bram Crotty recently sold 441 shares of Stryke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-stryker-executive-makes-eye-catching-move-with-fresh-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-stryker-executive-makes-eye-catching-move-with-fresh-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","LU2362540622.SGD","IHI","BK4588","LU2324357040.USD","LU0882574055.USD","BK4082","BK4566","LU2404859667.USD","LU0528227936.USD","LU2362541273.HKD","LU0690374615.EUR","LU0114720955.EUR","LU0690374961.EUR","LU0289739699.SGD","LU1791710400.SGD","LU0823417653.USD","LU2362541513.USD","LU1983299246.USD","GB00B4LPDJ14.GBP","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","LU2506952097.USD","LU2404859741.USD","LU2506952170.USD","LU2506951875.HKD","BK4504","LU0432979614.USD","LU0823417737.USD","BK4585","SYK","LU0950375773.USD","LU2506951958.HKD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740824","title":"Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740824","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740824?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:01","pubTimestamp":1787781675,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences CVP JAPAC Wayne Markowitz sells 1,240 shares for $113,416.60Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences, sold 1,240 common shares on Aug. 26, 2026.Sale price USD 91.47 per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5DN1jQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","SGXZ57979304.SGD","AGNG","BK4585","BK4082","LU0289739699.SGD","LU0823416689.USD","SG9999013999.USD","LU0345774631.USD","IHI","IE00BN0W2W23.USD","SG9999001176.USD","EW","BMED","IE00BN0W2V16.EUR","BK4504","IE00BYQQ9H92.USD","SG9999001176.SGD","LU0345774391.USD","IE00BN0W2T93.GBP","BK4567","BK4588","IE00BFXG0V08.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}